Literature DB >> 24256543

A novel method for the measurement of reflux from intravitreal injections: data from 20 porcine eyes.

Frank L Brodie1, Jason Ruggiero, Devon H Ghodasra, Kian Eftekhari, James Z Hui, Alexander J Brucker, Brian L VanderBeek.   

Abstract

BACKGROUND: Reflux following intravitreal injection is a common phenomenon, but it is unknown how much, if any, medication is lost as a result. Reflux is known to be a combination of vitreous and the injected agent, but the relative composition is unknown. This article describes a novel method for the measurement of the volume and composition of reflux and presents data from porcine eyes.
METHODS: Twenty porcine eyes were injected with 0.05 ml of dye at intraocular pressures (IOPs) of 15, 20, 25 and 30 mmHg (five eyes per subgroup). Reflux was captured on filter paper and the area of saturation and color intensity of the dye were digitally analyzed. Total refluxed volume and proportion of dye versus vitreous fluid were calculated from linear regression lines created from known standards.
RESULTS: Average (median) total volume of reflux from all eyes was 1.19 μl (0.93 μl), volume of injected dye refluxed was 0.47 μl (0.11 μl) and composition of reflux was 20.8% dye (15.5%). Less than 1% of the injected dye was lost to reflux. There were no differences between IOP groups in the total volume refluxed, the total amount of dye refluxed, the average composition of the reflux or the amount of injected dye refluxed (df = 3 for all comparisons; p = 0.58, p = 0.51, p = 0.55, p = 0.51, respectively).
CONCLUSIONS: This novel method allows for measurement of quantity and composition of reflux following intravitreal injection in vitro. While reflux occurs frequently, it is predominantly composed of vitreous, not the injected agent. In fact, <1% of the original injection was lost to reflux.

Entities:  

Keywords:  Intravitreal injection; reflux

Mesh:

Substances:

Year:  2013        PMID: 24256543      PMCID: PMC4028430          DOI: 10.3109/02713683.2013.864774

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  16 in total

1.  Accuracy and precision of intraocular injection volume.

Authors:  Jhansi R Raju; David V Weinberg
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

2.  Experimental model of intravitreal injection techniques.

Authors:  Jean-Pierre Hubschman; Robert E Coffee; Jean-Louis Bourges; Fei Yu; Steven D Schwartz
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

3.  Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection.

Authors:  Eduardo B Rodrigues; Astor Grumann; Fernando M Penha; Helio Shiroma; Eglas Rossi; Carsten H Meyer; Vinicius Stefano; Maurício Maia; Octaviano Magalhaes; Michel E Farah
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-12       Impact factor: 2.671

4.  Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits.

Authors:  Rafael T Cortez; Gema Ramirez; Lucienne Collet; Pranjal Thakuria; G Paolo Giuliari
Journal:  Arch Ophthalmol       Date:  2010-07

5.  Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous.

Authors:  John B Christoforidis; Michelle M Williams; Frank M Epitropoulos; Michael V Knopp
Journal:  Clin Exp Ophthalmol       Date:  2013-08       Impact factor: 4.207

6.  Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  Matthew S Benz; Thomas A Albini; Eric R Holz; Rohit R Lakhanpal; Andrew C Westfall; Mohan N Iyer; Petros E Carvounis
Journal:  Ophthalmology       Date:  2006-05-02       Impact factor: 12.079

7.  Noncontact and contact pars plana transscleral neodymium: YAG laser cyclophotocoagulation in postmortem eyes.

Authors:  H D Schubert
Journal:  Ophthalmology       Date:  1989-10       Impact factor: 12.079

8.  The effects of injection site on the reflux following intravitreal injections.

Authors:  Burak Turgut; Tamer Demir; Ulku Celiker
Journal:  J Clin Med Res       Date:  2009-12-28

9.  Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis.

Authors:  Olivier Gavet; Jonathon Pines
Journal:  Dev Cell       Date:  2010-04-20       Impact factor: 12.270

10.  Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited.

Authors:  Tamara A Potapova; Sushama Sivakumar; Jennifer N Flynn; Rong Li; Gary J Gorbsky
Journal:  Mol Biol Cell       Date:  2011-02-16       Impact factor: 4.138

View more
  4 in total

1.  A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.

Authors:  G Srividya; M Jain; K Mahalakshmi; S Gayathri; R Raman; N Angayarkanni
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

2.  Volume and composition of reflux after intravitreal injection.

Authors:  Frank L Brodie; Jason Ruggiero; Devon H Ghodasra; James Z Hui; Brian L VanderBeek; Alexander J Brucker
Journal:  Retina       Date:  2014-07       Impact factor: 4.256

3.  Comparison between two intravitreal injection techniques with respect to fluid reflux, intraocular pressure, and therapeutic effect.

Authors:  Shashi Tanwar; Arun Kumar Sharma; Rajat Mohan Srivastava; Vishal Katiyar; Siddharth Agrawal; Sanjiv Kumar Gupta
Journal:  Oman J Ophthalmol       Date:  2021-02-27

4.  Survey of intravitreal injection techniques among retina specialists in Israel.

Authors:  Ori Segal; Yael Segal-Trivitz; Arie Y Nemet; Noa Geffen; Ronit Nesher; Michael Mimouni
Journal:  Clin Ophthalmol       Date:  2016-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.